Pabau Engage inbox

Pabau Engage is here: every patient conversation in one inbox.

Learn more
Book a demo Book a demo
☰
ICD-10-CM Code

ICD code Q79.60 – Ehlers-Danlos syndrome, unspecified

Billable Code Specific Code


Code Definition

Q79.60 is the billable ICD-10-CM code for Ehlers-Danlos syndrome, unspecified. It applies when a provider has diagnosed EDS but the subtype is not yet confirmed, most often during the workup before genetic results arrive.

EDS spans 13 recognized subtypes, most with identifiable genetic markers and distinct clinical profiles. Once testing or specialist review names the subtype, the claim moves to Q79.61, Q79.62, Q79.63 or Q79.69.

Chapter
Q00-QA1 Congenital malformations, deformations, chromosomal abnormalities, and genetic disorders
Category
Q79 Congenital malformations of musculoskeletal system, not elsewhere classified
Group
Q79.6 Ehlers-Danlos syndromes
Billable
Yes
Code also known as
EDS, Ehlers Danlos, connective tissue disorder, hereditary collagen disorder, EDS unspecified type
Save time. Improve accuracy. Get paid faster.
Automate coding with Pabau

Let Pabau's smart automation suggest the right codes, reduce claim denials, and keep your practice compliant—effortlessly.

  • AI-powered code suggestions
  • Real-time compliance checks
  • Faster claims, fewer denials
Why practices choose Pabau
Save hours every week

Automate repetitive tasks and focus on what matters most—your patients.

Improve accuracy

Reduce coding errors and ensure compliance with the latest regulations.

Get paid faster

Clean claims, fewer denials, and faster reimbursements.

Grow with confidence

Powerful insights and reporting to help your practice thrive.

HIPAA compliant SOC 2 certified GDPR-compliant Trusted by 4,000+ clinics worldwide

Key takeaways

Key takeaways

Q79.60 is a valid, billable ICD-10-CM code for EDS when the documented subtype is unconfirmed.

Parent code Q79.6 is a non-billable category header and never belongs on a claim.

Once genetic testing confirms the subtype, payers expect the specific code from Q79.61 to Q79.69.

The note needs an EDS diagnosis from a qualified provider plus a statement that the subtype is unspecified or pending.

ICD-10 Code Q79.60: Definition and clinical context

ICD-10 Code Q79.60 identifies Ehlers-Danlos syndrome of unspecified type, a hereditary connective tissue disorder caused by defects in collagen structure or processing.

CMS’s FY2027 ICD-10-CM code files list it as a billable code in Chapter 17 (Congenital malformations, deformations, chromosomal abnormalities, and genetic disorders, Q00-QA1). That placement reflects the condition’s congenital origin rather than an acquired or inflammatory process.

Three cardinal features commonly appear in documentation supporting this diagnosis: joint hypermobility, skin hyperextensibility, and atrophic scarring (widened or thin scars).

Not every patient presents with all three, and severity varies widely across subtypes. When a clinician documents EDS but cannot yet name the subtype, Q79.60 is the correct assignment.

The 2017 EDS International Classification, published by Malfait et al. in the American Journal of Medical Genetics, recognized 13 EDS subtypes. Each subtype has distinct diagnostic criteria, and most have an identifiable genetic cause.

The major exception is hypermobile EDS (hEDS), which as of the 2017 classification has no confirmed genetic marker. Coders sometimes confuse Q79.60 with Q79.62 (hypermobile EDS) for that reason, since both can describe a patient without a genetic answer.

Code hierarchy: Where Q79.60 sits in ICD-10-CM

The parent-child structure explains the most common submission error on EDS claims, which is reporting Q79.6 in place of Q79.60.

LevelCodeDescriptionBillable?
ChapterQ00-QA1Congenital malformations, deformations, chromosomal abnormalities, and genetic disordersNo
BlockQ65-Q79Congenital malformations and deformations of the musculoskeletal systemNo
CategoryQ79.6Ehlers-Danlos syndromesNo (header only)
Leaf nodeQ79.60Ehlers-Danlos syndrome, unspecifiedYes

Q79.6 is a category header. The CMS ICD-10-CM code files explicitly flag Q79.6 as invalid for submission because it has subcodes. Submitting Q79.6 on a claim produces an automatic rejection. Q79.60 is the minimum specificity required for claim submission when the subtype is unconfirmed.

Complete list of Ehlers-Danlos syndrome ICD-10 codes (Q79.6x family)

Check the full Q79.6x family before assigning the unspecified code, because four of its five billable codes name a confirmed subtype. The subtypes below follow the 2017 EDS International Classification.

CodeEDS subtypeKey distinguishing featureGenetic marker
Q79.60UnspecifiedSubtype not confirmed or pending workupUnknown/not yet tested
Q79.61Classical EDS (cEDS)Severe skin extensibility, widened atrophic scars, smooth velvety skinCOL5A1 / COL5A2
Q79.62Hypermobile EDS (hEDS)Generalized joint hypermobility, musculoskeletal pain, no skin fragilityNone identified (as of 2017)
Q79.63Vascular EDS (vEDS)Arterial rupture, translucent skin, characteristic facial featuresCOL3A1
Q79.69Other specified EDSNamed subtypes not captured by Q79.61-Q79.63 (e.g. kyphoscoliotic, dermatosparaxis)Varies by subtype

Use the CDC/NCHS ICD-10-CM web tool to verify active code status for each Q79.6x subcode against the current fiscal year’s tabular list before submitting claims.

When to use Q79.60 vs specific subtype codes

Q79.60 is correct when the provider’s documentation states that the EDS subtype is unconfirmed, unknown, or pending further evaluation. The clinician’s note drives that choice. A coder who is unsure which subtype applies queries the provider before reaching for the unspecified code. The chart below maps each documented finding to its code.

Decision chart for Ehlers-Danlos syndrome ICD-10-CM codes
Only an open subtype keeps a claim on Q79.60, and every confirmed subtype has its own code. Descriptors from the CMS FY2027 ICD-10-CM code files.

Three clinical situations justify Q79.60:

  • Pre-diagnostic stage: The patient presents with EDS-consistent features and the provider documents an EDS diagnosis pending genetic confirmation or specialist review.
  • Subtype still undetermined after testing: Genetic testing is complete, but the results are inconclusive or the phenotype matches no recognized subtype in the 2017 classification.
  • Referral without a subtype: The referring provider diagnosed EDS without specifying a subtype, and the treating provider’s encounter note reflects the same uncertainty.

Once a clinical geneticist confirms the subtype, update the claim to the matching Q79.6x code. Continuing to use Q79.60 after genetic confirmation exposes claims to denial on specificity grounds. ICD-10-CM guidelines require the highest level of specificity the documentation supports, and that rule applies to every code on the claim.

Clinical documentation requirements for ICD-10 Code Q79.60

Valid use of ICD-10 Code Q79.60 requires documentation that supports both the EDS diagnosis and the unspecified designation. A missing element gives a payer reviewer grounds to question the claim.

  • Provider attestation: A physician or qualified specialist (typically a clinical geneticist, rheumatologist, or neurologist) must document the EDS diagnosis directly in the encounter note.
  • Clinical features: The note should record some combination of the cardinal features: joint hypermobility, skin hyperextensibility, atrophic scarring, and tissue fragility. Add any relevant family history.
  • Subtype status: The note must state explicitly that the subtype is unspecified, pending genetic workup, or unknown. Without this language, a reviewer may argue that a more specific code should have been used.
  • Referral or evaluation context: A documented referral to a clinical geneticist strengthens the medical necessity case for Q79.60. So does a note that genetic results are outstanding.

According to the AAPC ICD-10-CM coding resources, coders should code only what the provider documents. When the documentation cannot support a specific code, they query the provider.

Never assign Q79.62 (hypermobile EDS) based on observed joint hypermobility alone if the provider has not specifically documented that subtype.

Pro Tip

Run a documentation audit on Q79.60 encounters every quarter. Flag any chart where the provider note lacks an explicit statement about subtype status. Without a phrase such as ‘subtype pending genetic testing’, a valid claim can turn into a denial that needs an appeal and attachments.

Payer requirements and prior authorization for Q79.60

HIPAA mandates the use of ICD-10-CM diagnosis codes on all covered entity claims effective October 1, 2015. Beyond that baseline, payer-specific policies govern what services attached to Q79.60 require prior authorization (PA). These vary by MAC (Medicare Administrative Contractor), commercial plan, and state Medicaid program.

Services commonly triggering PA with Q79.60 include genetic testing referrals, physical and occupational therapy, durable medical equipment (orthotic bracing), and specialty medications for pain management.

Service typePA common?Documentation to attach
Genetic testing referralOften yesClinical notes, family history, EDS diagnosis statement
Physical therapy (PT)Varies by planFunctional limitations, PT evaluation, referral script
DME / orthoticsOften yesCertificate of medical necessity, provider order
Specialty medicationsOften yesPrior treatment failures, clinical justification letter

Always check the applicable Local Coverage Determination (LCD) for the MAC jurisdiction before submitting. LCDs set the Medicare coverage terms for services billed with Q79.60, such as physical therapy, and they differ by region. For an EDS patient starting physical therapy, confirming the LCD before the initial visit avoids retroactive denials.

Common claim denial reasons for Q79.60 and how to prevent them

Claims with Q79.60 draw specificity challenges, because the unspecified designation invites a payer to ask for a subtype. Effective denial management workflows for these claims start with the five common denial triggers below.

Denial reasonPrevention action
Submitted Q79.6 (non-billable header) instead of Q79.60Configure EHR code search to flag Q79.6 as a non-billable header; always select Q79.60 at minimum
Payer demands a subtype-specific codeAttach documentation stating genetic subtyping is pending or inconclusive; cite the 2017 EDS Classification criteria
Missing medical necessity documentationAttach the encounter note, clinical features list, and any specialist referral with every initial claim
PA not obtained before serviceVerify PA requirements against the applicable LCD before scheduling genetic testing or PT
Wrong sequencing: Q79.60 as secondary when it should be primarySequence Q79.60 as the principal diagnosis when the encounter is for EDS management; use as secondary when the encounter reason is a manifestation

When an appeal is necessary, the medical billing denial codes the payer returns (CARC codes) tell the team which documentation to resubmit. That beats sending a blanket appeal.

Coding and sequencing guidelines for Q79.60

The ICD-10-CM Official Guidelines for Coding and Reporting, maintained jointly by CMS and the National Center for Health Statistics (NCHS), govern how Q79.60 is sequenced.

Chapter 17 Q-codes follow the general rules for congenital conditions. A congenital condition codes to the Q chapter at any age, whether it is newly diagnosed or has been managed for years.

  • Principal diagnosis: Sequence Q79.60 first when the encounter is for the EDS diagnosis itself. The same applies to managing its core manifestations or starting a treatment plan.
  • Secondary diagnosis: Some encounters are mainly for a manifestation of EDS, such as chronic widespread pain, autonomic dysfunction, or joint subluxation. Code the manifestation as the principal diagnosis, then add Q79.60 as a secondary code to establish the underlying cause.
  • Additional codes for manifestations: Code any significant manifestations separately using appropriate codes from other chapters. Common additions include G89.29 for other chronic pain, M35.7 for hypermobility syndrome, or codes from the autonomic nervous system block.

The key to submitting a clean claim with Q79.60 is confirming the encounter reason drives the sequencing decision, not the diagnosis alone. For practices unfamiliar with congenital code sequencing, reviewing medical billing fundamentals alongside Chapter 17 guidelines helps build that judgment systematically.

Pro Tip

Check the admission or encounter reason documented in the note before assigning principal diagnosis. For EDS patients, the encounter reason shifts frequently: one visit is for PT evaluation (manifestation primary), the next is a genetics consultation (Q79.60 primary). Copying one visit’s sequencing onto the next is an easy error to make on multi-visit EDS accounts.

The ICD-10-CM tabular list does not carry Excludes1 or Excludes2 notes directly on Q79.60 that restrict common comorbidities. Coders should, however, be aware of related codes frequently reported alongside Q79.60 and codes that require careful distinction.

CodeDescriptionRelationship to Q79.60
M35.7Hypermobility syndromeDistinct diagnosis; may coexist but is not interchangeable with Q79.60 or Q79.62
G89.29Other chronic painCommonly reported alongside Q79.60 to capture the chronic pain manifestation
G90.3Multi-system degeneration of the autonomic nervous systemAutonomic dysfunction is documented in a subset of EDS patients; code separately when documented
M53.3Sacrococcygeal disorders, NECMay appear in EDS patients with coccyx pain (coccygodynia); code when documented separately

M35.7 is the code most often confused with Q79.62 (hypermobile EDS). The two are distinct diagnoses. M35.7 describes hypermobility without the full EDS diagnostic framework, while Q79.62 means the patient meets the 2017 criteria for hEDS.

Never swap these codes based on clinical appearance alone, and query the provider if the documentation uses both terms without distinction.

How to report Q79.60 in practice management software

Accurate reporting of ICD-10 Code Q79.60 starts with how the code is entered at the point of service documentation. Most EHR and practice management systems allow code lookup by either the numeric code (Q79.60) or the descriptor phrase (Ehlers-Danlos syndrome unspecified).

Searching by descriptor is safer for rare codes because it surfaces the full Q79.6x family. Coders can then confirm Q79.60 is the correct leaf node rather than the category header Q79.6.

  • Confirm the code is active for the date of service (DOS): CMS and NCHS release annual updates on October 1. A Q79.6x code that was valid in FY2026 may carry a different descriptor or status in FY2027. Always confirm against the current fiscal year’s tabular list.
  • Link to the CPT procedure code: The payer’s medical necessity crosswalk connects the ICD-10 diagnosis code to the CPT procedure code billed. Genetic testing, PT evaluation, and specialty consultations each have specific CPT codes that must align with Q79.60 to pass edits.
  • Attach supporting documentation: For initial claims with Q79.60, attach the encounter note, the clinical feature documentation, and any referral letters before submitting.
  • Flag Q79.6 as invalid: Configure code validation rules in the EHR to block Q79.6 as a standalone claim code. A clean-claim rule set catches this error before it reaches the clearinghouse.

How Pabau keeps Q79.60 claims and authorizations on track

An EDS patient often moves between genetics, physical therapy and pain management, and each service can carry its own authorization and diagnosis code. When those details live in spreadsheets, the billing team loses track of which approval expires and which visit needs Q79.60 as the principal diagnosis.

Pabau, a practice management platform with built-in claims management software, sends US claims through the Claim.MD clearinghouse. Practices check patient eligibility, submit CMS-1500 and 837P claims, and post ERA remittances against the same patient record.

Prior authorizations sit on the patient’s case, with the auth code, dates and sessions tracked and a warning when one is missing. Genetic testing, therapy and bracing for EDS often need separate approvals. Tracking them on the case keeps a missing authorization from surfacing as a denial weeks later.

Keep EDS claims and authorizations on track

Pabau checks eligibility, tracks prior authorizations on the patient’s case, and submits claims through Claim.MD. Claims for complex diagnoses like Q79.60 go out with the authorization already on file.

Pabau practice management software dashboard

Conclusion

Q79.60 is a holding code. It is correct while the subtype is open. Once genetics names the subtype, a claim that still says unspecified starts costing the practice money.

The deciding work happens in the provider’s note. Ask providers to state the subtype status in words at every EDS encounter, and recode to Q79.61 through Q79.69 the day a result arrives. Keep Q79.6 off your code picklist entirely.

Book a demo to see how Pabau tracks EDS authorizations and claims from the first referral to the final remittance.

Continue your research

Continue your research

Need to understand how clearinghouse submission works for rare diagnosis codes? Medical claims clearinghouse guide explains how payer connectivity and claim validation reduce rejections before they reach the insurer.

Getting repeated denials on ICD-10 submissions? Electronic remittance advice explained breaks down how to read ERA files and identify the CARC denial codes driving Q79.60 rejections.

Want to verify Q79.60 coverage with a specific payer before submitting? Insurance eligibility verification guide covers how to check plan-specific diagnosis code coverage before the appointment.

Frequently asked questions

What is ICD-10 Code Q79.60?

ICD-10 Code Q79.60 is the billable ICD-10-CM diagnosis code for Ehlers-Danlos syndrome, unspecified. It is assigned when a clinician has confirmed an EDS diagnosis but the specific genetic subtype has not been identified or documented. It sits under category Q79.6 (Ehlers-Danlos syndromes) in Chapter 17 (Congenital malformations, deformations, chromosomal abnormalities, and genetic disorders, Q00-QA1). The CMS code files flag it as valid for submission.

Is Q79.60 a billable ICD-10 code?

Yes. Q79.60 is a valid, billable leaf-node code in ICD-10-CM. Its parent, Q79.6, is not billable and must never appear on a claim submission. Q79.60 is the minimum specificity required when the EDS subtype is unconfirmed.

What is the difference between Q79.60 and Q79.61?

Q79.60 covers unspecified EDS when the subtype is unknown or pending confirmation. Q79.61 is specific to classical EDS (cEDS), which is characterized by severe skin extensibility and widened atrophic scars and is associated with COL5A1/COL5A2 variants. Use Q79.61 only when the provider has documented classical EDS based on clinical criteria and genetic testing.

Can Q79.60 be used without genetic confirmation?

Yes. Q79.60 is designed for use when genetic subtyping is pending or unavailable. The code is valid as long as a qualified provider has documented an EDS diagnosis with a statement that the subtype is unspecified. Genetic confirmation is not required to assign Q79.60, but once it is available, update the claim to the matching Q79.6x subtype code.

What is the parent code for Q79.60?

The parent code is Q79.6 (Ehlers-Danlos syndromes), which is a non-billable category header. Q79.60 is the first billable subcode under Q79.6 and represents the unspecified subtype. Never submit Q79.6 alone on a claim because it lacks the specificity required for payer acceptance.

Why are claims with Q79.60 denied?

Five reasons come up most often. A claim reports the non-billable parent Q79.6 instead of Q79.60, or the payer wants a subtype code after genetic testing is complete. Other claims lack medical necessity documentation, or prior authorization for genetic testing or PT. The fifth is sequencing, where Q79.60 is listed as secondary on an encounter for EDS management.

Avatar photo
Anja Dodevska
Content Writer

Anja Dodevska writes about healthcare, dermatology, and the day-to-day realities of running a medical practice for Pabau. She enjoys breaking down complex topics into clear, accessible content and has a soft spot for the often-overlooked aspects of clinic life. When she's not writing, she's exploring cafes, walking her dog, or spending time with friends and family.
×